Company Overview
BIOXCEL THERAPEUTICS, INC.
BTAIRevenue vs. Cost of Revenue
Revenue
Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses
Operating Income
Net Income
Net Income
Revenue
1M
2025 FY
Net Income
-70M
2025 FY
Shares Outstanding
12M
2025 FY
EPS
-5.73USD
2025 FY
Company Information
SIC Code
2834
CIK Code
1720893
Exchange
Nasdaq
Location
US